Including Children with High-Grade CNS Tumors in Existing Labels: The Possibilities of Real-World Evidence
dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Bloem, Lourens | |
dc.contributor.author | Bongers, Luuk | |
dc.date.accessioned | 2024-01-06T00:01:18Z | |
dc.date.available | 2024-01-06T00:01:18Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/45785 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | Het onderzoeken van de mogelijkheden die RWE biedt bij het uitbreiden van labels van oncolytica zodat ze ook kinderen omvatten. Op deze manier het off-label gebruik, en de bijbehorende risico's, verminderen. | |
dc.title | Including Children with High-Grade CNS Tumors in Existing Labels: The Possibilities of Real-World Evidence | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Farmacie | |
dc.thesis.id | 26878 |